Lawmakers on both sides of the aisle in the House and Senate are calling for COVID-era flexibilities on telemedicine services to be extended to ensure access to 'necessary and life-saving treatments,' and are speaking out against a proposed rule reportedly being advanced by the DEA that would limit telemedicine prescribing. The proposed rule would reportedly require that no more than half of a prescriber's prescriptions be given through telemedicine. The rule would also reportedly make prescribing schedule II substances like Adderall virtually impossible.
